Evidence map›Paper›PMID 39344233›Full record

Observational studyJournal of integrative neuroscience2024

Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease.

Jaimie Barr, Robert Vangel, Prabesh Kanel, Stiven Roytman, Chatkaew Pongmala, Roger L Albin, Peter J H Scott, Nicolaas I Bohnen

2 registry-linked trialsAbstract readObservational Study
In one paragraph

Observational study in Journal of integrative neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02458430 completednot on this map

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease - Clin Core/Proj#2

TypeobservationalSponsorUniversity of MichiganRan2015 to 2020Enrolled120ConditionsParkinson's Disease
NCT05459753 naactive not recruitingnot on this map

Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)

TypeinterventionalSponsorUniversity of MichiganRan2022 to 2027Enrolled125ConditionsParkinson Disease, Progressive Supranuclear PalsyArms(18)F]fluoroethoxybenzovesamicol ([(18)F (FEOBV) PET, Dihydrotetrabenazine (DTBZ) PET
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jaimie BarrDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Robert VangelDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Prabesh KanelDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Stiven RoytmanDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Chatkaew PongmalaDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Roger L AlbinParkinson's Foundation Research Center of Excellence, University of Michigan, Ann Arbor, MI 48109, USA.
Peter J H ScottDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Nicolaas I BohnenDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.

Funding

Tomography and Data AnalysisP01NS015655 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FREY, KIRK A. · 1985 to 2012
$13.0M
Udall Catalyst Research Project: Retrosplenial Cholinergic and Attentional-Motor Integration DysfunctionP50NS123067 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AHMED, OMAR JAMIL · 2021 to 2025
$11.6M
Public Outreach and Education CoreP50NS091856 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAUER, WILLIAM T. · 2014 to 2019
$10.1M
Central cholinergic presbyvestibulopathy network changes and imbalance in Parkinson's disease and older personsR01AG073100 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHNEN, NICOLAAS IDA · 2021 to 2025
$3.0M
Hyposmia, Cholinergic Denervation and Incipient Cognitive Decline in PDR01NS070856 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHNEN, NICOLAAS IDA · 2010 to 2014
$1.9M
Amyloidopathy, cholinopathy, dopamine responsiveness and freezing of gait in PDI01RX001631 · VA · VETERANS HEALTH ADMINISTRATION · PI BOHNEN, NICOLAAS IDA · 2016 to 2020
–
Farmer Family FoundationMichael J. Fox FoundationNIA NIH HHS R01 AG073100NIH HHS P01 NS015655NIH HHS P50 NS091856NIH HHS P50 NS123067NIH HHS R01 AG073100NIH HHS R21 NS114079NIH HHS RO1 NS070856NINDS NIH HHS P01 NS015655NINDS NIH HHS P50 NS091856NINDS NIH HHS P50 NS123067NINDS NIH HHS R01 NS070856Parkinson's FoundationRRD VA I01 RX001631
6 · The paper itself

Abstract

backgroundPostural instability and gait disturbances (PIGD) represent a significant cause of disability in Parkinson's disease (PD). Cholinergic system dysfunction has been implicated in falls in PD. The occurrence of falls typically results in fear of falling (FoF) that in turn may lead to poorer balance self-efficacy. Balance self-efficacy refers to one's level of confidence in their ability to balance while completing activities of daily living like getting dressed, bathing, and walking. Lower self-efficacy, or greater FoF during these activities is a function of motor, cognitive, and emotional impairments and may impact quality of life in PD. Unlike known cholinergic reduction, especially in the right lateral geniculate and caudate nuclei, little is known about the role of cholinergic transporters in FoF or mobility self-efficacy in PD.

methods[

resultsReduced [

conclusionsUnlike the more limited involvement of the brainstem-thalamic complex and caudate nuclei cholinergic topography associated with falls in PD, cholinergic reductions in the extended connectivity between the thalamic complex and the temporal limbic system via the fimbriae associates with FoF. Additional cholinergic changes were seen in the cerebellum. The temporal limbic system plays a role not only in episodic memory but also in spatial navigation, scene and contextual ( CLINICAL

trial registrationNo: NCT02458430. Registered 18 March, 2015, https://www. CLINICALTRIALS: gov/study/NCT02458430; No: NCT05459753. Registered 01 July, 2022, https://www. CLINICALTRIALS: gov/study/NCT05459753.

Indexed as

Parkinson DiseasePositron-Emission TomographyPostural BalanceSelf EfficacyAccidental FallsAgedBrainCholinergic NeuronsFemaleHumansMaleMiddle AgedVesicular Acetylcholine Transport ProteinsVesicular Acetylcholine Transport Proteinscholinergic systemsfear of fallingParkinson's diseasepositron emission tomographyself-efficacy

Identifiers

PMID39344233
PMCPMC12084976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.